Cita APA

Mateos, M., Martínez López, J., Rodriguez-Otero, P., Gonzalez-Calle, V., González, M. S., Oriol, A., . . . San Miguel, J. F. (2024). Curative Strategy for High-Risk Smoldering Myeloma: Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Followed by Transplant, KRd Consolidation, and Rd Maintenance.

Citación estilo Chicago

Mateos, María-Victoria, et al. Curative Strategy for High-Risk Smoldering Myeloma: Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Followed By Transplant, KRd Consolidation, and Rd Maintenance. 2024.

Cita MLA

Mateos, María-Victoria, et al. Curative Strategy for High-Risk Smoldering Myeloma: Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Followed By Transplant, KRd Consolidation, and Rd Maintenance. 2024.